INTRODUCTION
Definition of the physiological and biochemical events associated with phagocytosis and intracellular killing by leukocytes has resulted in the description of several disorders of phagocyte metabolism associated with defective bacterial killing. The best known example, chronic granulomatous disease of childhood (CGD)' was first described by Berendes, Bridges, and Good in 1957 (1) . In 1966 Holmes, Quie, Windhorst, and Good (2) found that the disease was caused by inadequate killing of certain bacteria by the patient's leukocytes. Although phagocytosis was normal, ingestion of certain nonhydrogen peroxide-producing bacteria was followed by a prolonged intracellular survival of these organisms. This bactericidal defect of CGD leukocytes is characterized by deficient oxygen consumption, hexose monophosphate shunt activity (3, 4) , nitroblue tetrazolium reduction (4) , and hydrogen peroxide production (5), during phagocytosis. The enzymatic basis of H202 production in phagocytising leukocytes may be due to oxidase(s) which use NADH (6, 7) and oxygen as substrate. Other oxidases which use NADPH (8) or amino acids (9) have also been found in PMN, but their physiologic role during phagocytosis has not been clarified. The recent studies of 'Abbreviations used in this paper: CGD, chronic granulomatous disease; G6PD, glucose-6-phosphate dehydrogenase; HMPS, hexose monophosphate shunt; NBT, nitroblue tetrazolium; PMN, polymorphonuclear leukocytes.
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Klebanoff (10) have demonstrated that H202 combined with myeloperoxidase and halide ion, kills bacteria. The lack of killing in CGD cells can be improved in vitro by insertion of a H202-generating oxidase into their phagocytic vacuoles (11, 12) . The precise role of leukocyte hexose monophosphate shunt (HMPS) activity to H202 production and bacterial killing is uncertain. We have encountered a 52 yr old white female (F. E.) with recurrent and fatal Gram-negative infection and absent HMPS activity with low H202 production by her leukocytes during phagocytosis. This PMN lesion differed from CGD PMN's since the oxidases which produce H202 were normal (4) but reduced pyridine nucleotide generating glucose-6-phosphate dehydrogenase (G6PD) activity was completely absent, and methylene blue did not stimulate the hexose monophosphate shunt in F. E. leukocytes. The metabolic consequences of this deficiency are examined in this report. Red cell glucose-6-phosphate dehydrogenase, (G6PD) activity was low, and leucocyte glucose-6-phosphate dehydrogenase, (G6PD) was practically absent.
CASE REPORT
The family history was significant in that four brothers, three sisters, and the only living child (29 yr old male), had normal red cell and leukocyte glucose-6-phosphate dehydrogenase levels. An increased incidence of infection or occurrence of anemia or hemolysis was not elicited in the family. The patient's father had expired and her mother would not allow blood studies to be performed.
METHODS
Leukocyte isolation. Leukocytes were isolated largely free of platelets and red cells by sedimentation and gentle centrifugation from 50 cc of heparinized venous blood. The white cells were washed with 0.9% saline. They were then suspended in 6 ml of cold distilled water for red cell lysis, and isotonicity was restored with 2 ml of 3.5% salines. The resulting white cells were suspended in phosphate-buffered saline, counted in a Coulter counter (Coulter Electronics, Inc., Hialeah, Fla.), and brought to the desired concentration by adding phosphate-buffered saline to the cell suspension (13) . Viability was determined by 1% Trypan Blue.
Differentials were performed in the counting chamber by classifying cells as phagocytes (segmented and band-form neutrophils, eosinophils, and monocytes) and lymphocytes. The lymphocytes accounted for less than 10%o of the isolated cell suspension. In addition, differentials were performed on peripheral blood prepared with Wright's stain. The degree of maturity remained constant throughout the study.
Quantitative nitroblue tetrazolium test. Quantitation of the reduction of nitroblue tetrazolium to the insoluble blue formazan was done by the method of Baehner and Nathan (14) .
Metabolic studies. Leukocyte oxygen consumption was measured using the oxygen electrode polarographic method as previously described (6) .
Hydrogen peroxide production was measured by determining the amount of '4CO2 generated from Nae4COOH. 1 ,uCi of 1'C Na"COOH formate was added to 0.8 cc of the leukocyte suspension containing 4 X 107 cells/mm'. Then 0.1 cc of polystyrene particles was added to the flask by a sidearm and the cells were allowed to phagocytize for 30 min at 37°C in a Dubnoff metabolic shaking incubator (Precision Scientific Co., Chicago, Ill.). 1'CO was trapped in a center vial with 0.1 cc of 10% sodium hydroxide. The reaction was stopped by transferring the flask to an ice bath where it revolved for 30 min to permit further 14CO2 diffusion from the incubation media. The alkali was then washed from the center well with 10 ml of scintillation fluid and the '4CO2 activity was counted in a Packard Tri-Carb (Packard Instrument Co., Inc., Downers Grove, Ill.) scintillation spectrometer.
Hexose monophosphate shunt activity and Krebs' cycle activity were determined by suitable modifications of the methods of Beck (15, 16) , and Sbarra and Karnovsky (17) utilizing glucose-l-'4C and glucose-6-14C, respectively.
Enzyme studies. For the in vitro measurement of enzyme activities, cells were suspended in phosphate-buffered saline and disrupted by sonication as previously described (13, 18) . Cellular debris was removed by centrifugation at 27,000 g for 15 min and the enzyme activities of supernates were then determined immediately. The protein concentration of sonicates was estimated by the biuret method (19) .
The activities of leukocyte 6-phosphogluconic acid dehydrogenase (20) and glucose-6-phosphate dehydrogenase (21) were measured spectrophotometrically. The initial rate of formation of NADPH was determined at 340 mt& in a Beckman DU spectorometer (Beckman Instruments, Inc., Fullerton, Calif.) with a Gilford recorder (Gilford Instrument Laboratories, Inc., Oberlin, Ohio). The enzyme activity in micromoles per minute was calculated using the molar extinction coefficient for NADPH of 6, 200 .
Red cells were hemolyzed in 4 volumes of 0.01 , Tris buffer, pH 7.4 at 0-4°C. Assays for red cell enzymes were performed on 0.10-ml portions of this hemolysate.
NADH and NADPH oxidase activities were determined according to the method of Cagan and Karnovsky (7) as modified by Baehner and Nathan (14) .
Acid and alkaline phosphatase, beta glucuronidase, and myeloperoxidase were assayed according to the methods previously reported (22 Electron microscopic studies of myeloperoxidase were performed by the method of Baehner, Karnovsky, and Karnovsky (22) . Iodination was performed by the method of Klebanoff (10) . Control and F. E. leukocytes were incubated with a culture of E. coli isolated f rom F. E., and Eagles-199 medium in the presence of "'I. Smears of these cellular suspensions were then fixed in absolute methanol and radioautographs were prepared.
RE SULTS A screening test for nitroblue tetrazolium reduction showed no evidence of NBT reduction. Subsequent studies showed that F. E. leukocytes failed to reduce nitroblue tetrazolium to the insoluble blue formazan over a 2 hr period (Fig. 1) , and nitroblue tetrazolium reduction was not observed in the phagocytic vacuoles of F. E. leukocytes. However, sonicates of F. E. leukocvtes did reduce nitroblue tetrazolitum normallv when NADPH or NADH was added to the reaction mixture.
Hexose monophosphate shunt activity wvith and without phagocytosis of polystyrene particles was studied in 20 normal individuals and in four separate studies on patient F. E. "4CO2 release from glucose-6-"C was normal in F. E. cells, but a total lack of hexose monophosphate shunt activity as measured by "4CO2 released from glucose-1-"4C was observed in both resting and phagocytizing states (Table I) results in patients with chronic granulomatous disease (3, 4) . Methylene blue stimulates hexose monophosphate shunt activity of PMN's from children with chronic granulomatous disease (4). In contrast, methylene blue did not stimulate the hexose monophosphate shunt in F. E. leukocytes (Table I) .
Hydrogen peroxide production was decreased compared to normals in resting and particularly in phagocvtizing CGD and F. E. leukocytes (Table II) zymes such as acid phosphatase, beta glucuronidase, and myeloperoxidase were quantitatively normal or increased (Table III) F. E. leukocytes to iodinate bacteria as compared to controls (Fig. 2) . Bactericidal studies revealed that F. E. cells killed hydrogen peroxide-producing organisms such as S. fae- calis (Fig. 3 ) but could not kill E. coli, S. aureus, or S. marcesccns, all of which are catalase positive and do not produce H202 (Fig. 4) . In addition to the complete deficiency of leukocyte glucose-6-phosphate dehydrogenase, depressed activity of this enzyme was found in red cell hemolysates (Table  VI) . However, the red cell study was performed after the patient was transfused with 2 U of packed red cells when the absolute reticulocyte count was 8%. Thus F. E.'s mature red cell glucose-6-phosphate dehydro- 
DISCUSSION
In contrast to Negroes with glucose-6-phosphate dehydrogenase deficiency, non-Negroes with this enzyme defect have more severely affected erythrocytes (24, 25) and decreased enzymatic activity in skin fibroblasts (26) , platelets (27) , saliva (28) , and leukocytes (29) . Our findings of a female Caucasian with moderately deficient red cell G6PD levels and a complete deficiency of leukocyte G6PD is unusual and has never previously been reported.
G6PD is coded by the same gene in leukocytes, erythrocytes, and other tissue cells, and there is an excellent correlation of the electrophoretic abnormalities of G6PD in both leukocytes and erythrocytes of affected variants (30) . However, as previously noted (24, 25) considerable differences in activity of the enzyme may be observed between erythrocytes and leukocytes, and in general the deficiency in activity of G6PD in the white cell is less than in the erythrocyte. Since patient F. E. had severely depressed leukocyte G6PD levels as compared to her erythrocytes, several hypotheses must be considered.
First, the hypothesis that the patient might be homozygous for one of the known X-linked genes resulting in G6PD deficiency can is an adaptive enzyme (32) .
In addition, the patient might be heterozygous for a previously undescribed mutant gene at the G6PD locus of the X-chromosome resulting in formation of a highly unstable variant of G6PD. This may be similar to the 774 Cooper, DeChatelet, McCall, LaVia, Spurr, and Baehner Philadelphia (Ph) chromosome marker of chronic myelogenous leukemia in which the Ph chromosome is found in erythrocytic and granulocytic precursors, but not in circulating lymphocytes (33) . The postulated variant might be much more unstable in the biochemical environment of the leukocyte than in that of the erythrocyte, and thus be destroyed rapidly and selectively in leukocytes. Even if one assumes a marked difference in stability of the enzyme in leukocytes and erythrocytes, it would still be necessary to assume that the X-chromosome bearing the mutant gene is the active one in most leukocytes.
Fifthly, the patient might be heterozygous for one of the known X-linked genes for G6PD. The finding of moderately reduced G6PD activity in her erythrocytes and the normal level in her son and sibling suggest this. The virtual absence of G6PD activity in her leukocytes could then be an expression of cellular mosaicism with inactivation of the normal X-chromosome in stem cells of the granulocytic cell line in accordance with the Lyon hypothesis (34, 35). Inactivation of one of the X-chromosomes may occur quite early in embryonic life (36, 37) , and by chance the X-chromosome bearing the mutant gene for G6PD deficiency may have remained active in the cell precursor to granulocytes in this patient, while the normal X-chromosome was inactivated. This hypothesis is compatible with the observation in this family. However, if leukocytes and erythrocytes have a common precursor cell (30) , another unknown genetic mechanism must be implicated.
It has been shown that white cells contain proteinases which can inactivate G6PD (38) . Whether decreased thermostability or the existence of autosomal modifying genes for G6PD could account for this deficiency is unknown. Thus, patient F. E. must be uniquely different from any previously reported G6PD variant. Additional genetic or environmental factors must exist to explain the marked variability in leukocyte G6PD activity observed in Caucasians with this enzymatic deficiency.
Caucasians with glucose-6-phosphate dehydrogenase deficiency have been found to have varying levels of this enzyme in their leukocytes. Rodney, Jacob, Holmes, McArthur, and Good (39) studied a patient with glucose-6-phosphate dehydrogenase deficiency with only 25% of normal levels in leukocytes. No metabolic or bactericidal defect was found. Ramot et al., (29) found 20% of normal glucose-6-phosphate dehydrogenase activity in leukocytes. No increased incidence of infections was noted in this population but functional studies were not performed on phagocytes.
Additional studies by Baehner, Johnston, and Nathan (40) in glucose-6-phosphate dehydrogenase-deficient Caucasians showed no metabolic defect when glucose-6-phosphate dehydrogenase was 20% of normal in phagocytes. However, a patient with only 5% glucose-6-phosphate dehydrogenase in leukocytes was found to have a reduced pyridine nucleotide pool with moderate functional impairment. Patient F. E. with nonspherocytic hemolytic disease secondary to glucose-6-phosphate dehydrogenase deficiency was found to have a complete absence of this enzyme in her leukocytes.
F. E. phagocytes shared many of the metabolic, morphologic, and bactericidal defects present in CGD cells. Both cells took up bacteria normally and discharged their granule hydrolyases into the phagocytic vacuoles (41) . Despite this, both cells failed to evince the oxidative burst that usually begins 1-2 min after particle uptake (42, 43) . The oxidation of glucose via the HMPS and H202-dependent formate oxidation did not occur. Neither cell killed those bacteria which themselves failed to generate H202, e.g., S. aureus and E. coli, yet both cells effectively killed peroxide-forming bacteria e.g. S. faecalis. The difference between F. E. and CGD cells was that F. E. cells completely lacked G6PD and had normal oxidase activity, whereas fresh CGD cells had normal levels of G6PD, but were deficient in oxidase activity. Hence, CGD cells demonstrated increased HMPS activity in response to methylene blue, but F. E. cells remained unstimulated because the substrate donor of electrons and H' ions, NADPH, was not produced in G6PD-deficient cells.
The metabolic basis for the bactericidal defect in F. E. cells, as well as CGD cells, would appear to be lack of activity of the H202-myeloperoxidase-halide system (44). Klebanoff (10) , and McRipley and Sbarra (45) , have demonstrated a synergistic effect between H202, myeloperoxidase, and an oxidizable substrate such as a halide ion. Strauss, Paul, Jacobs, and Sbarra (46) showed that myeloperoxidase-containing granules from guinea pig PMN catalyzed the deamination and decarboxylation of amino acids if H202 were added to the system. They further suggested that the aldehyde formed from the above reaction may be the volatile bactericidal substance proposed by Klebanoff. Myeloperoxidase was normal in F. E. cells and was degranulated into the phagocytic vacuole during phagocytosis. Lehrer and Cline (47) described a patient with disseminated candidiasis and absent PMN granule myeloperoxidase. There was defective killing of Candida albicans and other candida species as well as S. marcescens and S. aureus. Klebanoff (48) has shown that these cells do not iodinate bacteria since they lack an important component of the H202-myeloperoxidase-halide system, i.e. granule myeloperoxidase. Klebanoff (44) has further shown that CGD cells do not iodinate nonperoxide-forming bacteria within their phagocytic vacuoles. However, they do iodinate peroxideforming bacteria, since the latter bacteria provide the H2O which is not generated by CGD leukocytes during phagocytosis. The failure of F. E. cells to iodinate bacteria was most likely also due to failure of H202 generation during phagocytosis.
H202 is normally generated in PMN during phagocytosis as first noted by Iyer, Islam, and Quastel (5) who studied the catalatic oxidation of formate-"C by H202. Several H202-producing cyanide insensitive oxidase enzymes have been described in human PMN: NADPH oxidase (8), NADH oxidase (5, 6) and Damino acid oxidase (9) . Although neither reduced pyridine nucleotide oxidase was deficient in one group of CGD patients (3), NADH oxidase was found to be low in five children with the disease (49) . Amino acid oxidase activity was found to be normal in three children with CGD (50). Since F. E. cells had normal NADPH and NADH oxidase activity, this suggested that the substrates for oxidase activity were diminished in F. E. cells, i.e. NADPH and/or NADH. If H202 were produced from both substrates, then neither reduced pyridine nucleotide was available for the oxidase reaction in F. E.'s G6PD-deficient leukocytes. Methylene blue, a potent redox dye, failed to stimulate the HMPS in F. E. cells which indicates that at least NADPH was not available. Evans and Kaplan (51) have described a NADPH-NAD' transhydrogenase in human PMN, and such a shuttle mechanism may be important to provide the additional NADH needed for H202-producing oxidase activity in PMN.
Recently, Schlegal and Bellanti (52) hypothesized a relationship between glucose-6-phosphate dehydrogenase lability and/or deficiency and the increased susceptibility of males to infection. This concept was challenged by Rodney et al. (39) , who found no evidence for decreased bactericidal activity of leukocytes from two patients with Caucasian glucose-6-phosphate dehydrogenase deficiency whose white cells contained only 25% of normal glucose-6-phosphate dehydrogenase levels. This suggests that glucose-6-phosphate dehydrogenase capacity for hexose monophosphate shunt activity is much greater than that which is absolutely necessary for functional integrity of the shunt, and that the enzyme is only rate-limiting if severely depressed.
This observation was supported by the study of a patient with only 5% of normal leukocyte glucose-6-phosphate dehydrogenase activity. Metabolic and bactericidal defects similar to but milder than those of patient (F. E. were found (40) .
The patient (F. E.) with a complete deficiency of leukocyte glucose-6-phosphate dehydrogenase showed no evidence of hexose monophosphate shunt activity and, in addition, the hexose monophosphate shunt could not be stimulated with methylene blue. This suggests that activation of the hexose monophosphate shunt is important for adequate bactericidal activity of the polymorphonuclear leukocyte.
However, a recent study in one of our laboratories studying the effect of colchicine on polymorphonuclear metabolism raised a possibility of other mechanisms (53) . We found that colchicine, a potent inhibitor of glucose-6-phosphate dehydrogenase, could completely inhibit the respiratory burst, decrease nitroblue tetrazolium reduction by 50%, and partially inhibit iodination. However, there was no effect of colchicine on the ingestion and bactericidal activity of leukocytes. This would suggest that activation of the hexose monophosphate shunt is a secondary mechanism which occurs after the generation of H202 and that intracellular killing may occur in the absence of hexose monophosphate shunt activity.
Thus, the polymorphonuclear leukocyte is endowed with multiple killing mechanisms and most likely has an overkill capacity. However, patient F. E. with normal acid and alkaline phosphatase and beta glucuronidase levels, increased myeloperoxidase activity, and normal degranulation was shown to have a defect in iodination and an inability to kill non-H202-producing bacteria. This suggests that H202 is an extremely important component of the bactericidal system and that alternative killing mechanisms could not adequately compensate for this complete deficiency of glucose-6-phosphate dehydrogenase in the polymorphonuclear leukocyte.
Although the precise biochemical basis for H202 production during phagocytosis in human polymorphonuclear leukocytes may still be unsettled, this patient demonstrated that the integrity of the hexose monophosphate shunt is necessary for adequate H202 production and bacterial killing.
